{"id":"W2626352507","doi":"10.1089/nat.2017.0671","title":"Recommendations of the Oligonucleotide Safety Working Group's Formulated Oligonucleotide Subcommittee for the Safety Assessment of Formulated Oligonucleotide-Based Therapeutics","year":2017,"lang":"en","type":"article","venue":"Nucleic Acid Therapeutics","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":true,"ca_institutions":"Arbutus Biopharma (Canada)","funders":"","keywords":"Oligonucleotide; Computational biology; Drug development; Pharmacology; Drug; Computer science; Medicine; Risk analysis (engineering); Biology; Biochemistry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.09589106,0.002713358,0.001995582,0.005078399,0.004322467,0.006113439,0.01096409,0.02773795,0.00855776],"category_scores_gemma":[0.0756744,0.002300759,0.004247952,0.002963366,0.003406026,0.003441764,0.003897645,0.01749127,0.009682989],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.006427296,"about_ca_system_score_gemma":0.09008209,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02907827,"about_ca_topic_score_gemma":0.02596334,"domain_scores_codex":[0.9315417,0.02538572,0.01077957,0.002485885,0.02458293,0.005224172],"domain_scores_gemma":[0.8389987,0.03135551,0.01269127,0.005132237,0.1014925,0.01032985],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004154912,0.001085326,0.002207681,0.001918579,0.00011845,0.001217056,0.001544974,0.00406175,0.01484304,0.01822384,0.8344561,0.1199077],"study_design_scores_gemma":[0.0001361189,0.0003113558,0.002298655,0.002421878,0.0001356414,0.0002886119,0.000928886,0.00105259,0.004959859,0.007964239,0.9793689,0.0001333519],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"other","genre_scores_codex":[0.01396731,0.02177568,0.1188913,0.5522474,0.04814686,0.02997118,0.009976455,0.00183184,0.203192],"genre_scores_gemma":[0.03011411,0.02667494,0.3255929,0.2893186,0.0118734,0.02544674,0.01442832,0.0007944927,0.2757564],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.09589106,"threshold_uncertainty_score":0.5071265,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04017292619997519,"score_gpt":0.3121729157865303,"score_spread":0.2719999895865551,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}